Search Editorial Photos
"Phase 3 Study"
63 professional editorial images found
#6198108
19 November 2020
A medical syringe and a vial in front of the EU flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198110
19 November 2020
A medical syringe and a vial in front of the EU flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198112
19 November 2020
A medical syringe and a vial in front of the EU flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198114
19 November 2020
A medical syringe and a vial in front of the EU flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198116
19 November 2020
A vial in front of the EU flag reflected in glass is seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198118
19 November 2020
A medical syringe and a vial in front of the EU flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198120
19 November 2020
A medical syringe and a vial in front of the flag of China are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198122
19 November 2020
A medical syringe and a vial in front of the flag of China are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198126
19 November 2020
A medical syringe and vials in front of the Chinese flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198128
19 November 2020
A medical syringe and a vial in front of the British flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198130
19 November 2020
A medical syringe in front of the British flag is seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198132
19 November 2020
A medical syringe and a vial in front of the British flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198134
19 November 2020
A medical syringe and a vial in front of the British flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198136
19 November 2020
A medical syringe in front of the U.S. flag is seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198138
19 November 2020
A medical syringe and a vial in front of the U.S. flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198144
19 November 2020
A medical syringe and vials in front of the US flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.